Australia TGA

CAMP4 Therapeutics Receives Australian Clearance for First-in-Human CMP-002 Trial

CAMBRIDGE, Mass., July 27, 2026 CAMP4 Therapeutics announced that it has received regulatory clearance from Australia’s Therapeutic Goods Administration...

By cGxPwire Editor
July 28, 2026

Bio-Pharma

Australia Approves Amtagvi for Advanced Melanoma Care

SAN CARLOS, Calif., June 3, 2026 Iovance Biotherapeutics has announced that Australia’s Therapeutic Goods Administration (TGA) has granted approval...